Artificial Epidemics: How Medical Activism Has Inflated the Diagnosis of Prostate Cancer and Depression (Kindle Single)
Artificial Epidemics: How Medical Activism Has Inflated the Diagnosis of Prostate Cancer and Depression (Kindle Single)
by Stewart Justman
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $11.55
Used from: $2.64

Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $12.78
Used from: $12.78

The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
by John C. McHugh M.D.
Our Price: $13.24
Used from: $9.49

You Can Beat Prostate Cancer: And You Don't Need Surgery to Do It
You Can Beat Prostate Cancer: And You Don't Need Surgery to Do It
by Robert J. Marckini
Our Price: $20.00
Used from: $4.19



Prostate Tumor Links


<< 1 2 3 >>




Prostate Tumor News


Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes - GenomeWeb


New York Daily News

Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes
GenomeWeb
In an effort to get a more complete picture of the mutations involved in metastatic, treatment-resistant forms of the disease, Tomlins and his co-workers sequenced and compared the exomes of 50 extensively treated castration-resistant prostate tumors ...
Scientists discover new type of prostate cancerFox News
Scientists find new type of prostate cancer - discovery may lead to tailored ...New York Daily News
Scientists Discover Distinct Molecular Subtype of Prostate CancerCornell Chronicle
Daily News & Analysis
all 20 news articles »

Read more...


Prostate-Cancer Test Not Worth Risk, Panel Says - BusinessWeek


USA TODAY

Prostate-Cancer Test Not Worth Risk, Panel Says
BusinessWeek
The report cited the slow growth of most prostate tumors as well as false positive rates that may be as high as 80 percent. While doctors are still free to suggest PSA tests, they should be prepared to discuss the potential downsides, the report said.
Common prostate cancer test condemnedOmaha World-Herald
Panel advises against PSA cancer screeningUSA TODAY
US panel recommends against PSA tests for screening prostate cancer in men of ...CBS News
Plain Dealer
all 297 news articles »

Read more...